India to Myanmar: Carvedilol Export Trade Route
India has recorded 62 verified shipments of Carvedilol exported to Myanmar, representing a combined trade value of $870.1K USD. This corridor is served by 21 active Indian exporters, with an average shipment value of $14.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED , which accounts for 72% of total export value with 9 shipments worth $629.9K USD. On the buying side, MYIT MAHAR TRADING CO., LTD. is the largest importer in Myanmar with $477.3K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED, DELTA BIOPHARMA PRIVATE LIMITED — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Carvedilol corridor is one of India's established pharmaceutical export routes, with 62 shipments documented worth a combined $870.1K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED , which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's carvedilol manufacturing sector.
Across 21 active suppliers, the average shipment value stands at $14.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #14 among India's top carvedilol export destinations globally.
On the import side, key buyers of Indian carvedilol in Myanmar include MYIT MAHAR TRADING CO., LTD. , MYIT MAHAR TRADING CO., LTD , GOLDEN SPIRIT TRADING CO. LTD and 23 others. MYIT MAHAR TRADING CO., LTD. is the single largest importer with 7 shipments valued at $477.3K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#14
- Annual growth+30.2%
- Demand growth+25.2%
- Regulatory ease70/100
Top 10 Indian Carvedilol Exporters to Myanmar
Showing top 10 of 21 Indian suppliers exporting Carvedilol to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $70.0K per shipment | 9 | $629.9K | 72.4% |
| 2 | GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED Avg $9.7K per shipment | 9 | $86.9K | 10.0% |
| 3 | DELTA BIOPHARMA PRIVATE LIMITED Avg $7.2K per shipment | 7 | $50.4K | 5.8% |
| 4 | GLOBAL PHARMA HEALTH CARE PRIVATE LIMITED Avg $6.3K per shipment | 2 | $12.5K | 1.4% |
| 5 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED Avg $4.1K per shipment | 3 | $12.3K | 1.4% |
| 6 | ARAVIS PHARMACEUTICALS Avg $5.5K per shipment | 2 | $11.1K | 1.3% |
| 7 | SWISS GARNIER LIFE SCIENCES Avg $5.1K per shipment | 2 | $10.3K | 1.2% |
| 8 | MICRO LABS LIMITED Avg $4.3K per shipment | 2 | $8.7K | 1.0% |
| 9 | FOURRTS I LABORATORIES PRIVATE LIMITED Avg $7.0K per shipment | 1 | $7.0K | 0.8% |
| 10 | H JULES & COMPANY LTD Avg $5.5K per shipment | 1 | $5.5K | 0.6% |
This table shows the top 10 of 21 Indian companies exporting carvedilol to Myanmar, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED , GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED, DELTA BIOPHARMA PRIVATE LIMITED, GLOBAL PHARMA HEALTH CARE PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, ARAVIS PHARMACEUTICALS, SWISS GARNIER LIFE SCIENCES, MICRO LABS LIMITED , FOURRTS I LABORATORIES PRIVATE LIMITED, H JULES & COMPANY LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 9 shipments worth $629.9K USD, giving it a 72% market share. The top 3 suppliers together account for 88% of the total trade value on this route.
Showing top 10 of 21 total Indian exporters on the India to Myanmar Carvedilol export route.
Top 10 Carvedilol Importers in Myanmar
Showing top 10 of 26 known buyers in Myanmar receiving Carvedilol shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian carvedilol in Myanmar include MYIT MAHAR TRADING CO., LTD. , MYIT MAHAR TRADING CO., LTD , GOLDEN SPIRIT TRADING CO. LTD, PYREX TRADING CO LTD, Pyrex Trading Co Ltd,, among 26 total buyers. The largest importer is MYIT MAHAR TRADING CO., LTD. , accounting for $477.3K USD across 7 shipments — representing 55% of all carvedilol imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYIT MAHAR TRADING CO., LTD. | 7 | $477.3K | 54.9% |
| 2 | MYIT MAHAR TRADING CO., LTD | 2 | $152.6K | 17.5% |
| 3 | GOLDEN SPIRIT TRADING CO. LTD | 7 | $74.5K | 8.6% |
| 4 | PYREX TRADING CO LTD | 3 | $21.0K | 2.4% |
| 5 | Pyrex Trading Co Ltd, | 2 | $16.5K | 1.9% |
| 6 | NA | 4 | $16.2K | 1.9% |
| 7 | PYREX TRADING CO LTD, | 2 | $12.9K | 1.5% |
| 8 | M/S.RAMMAWADDY INTERNATIONAL CO.LTD | 2 | $12.1K | 1.4% |
| 9 | WIN WIN EXP IMP CO LTD,U LUN STREET | 2 | $11.1K | 1.3% |
| 10 | MINISTRY OF DEFENCE, | 2 | $10.3K | 1.2% |
Showing top 10 of 26 Carvedilol importers in Myanmar on this route.
Top 10 Carvedilol Formulations Imported by Myanmar
Showing top 10 of 39 product formulations shipped on the India to Myanmar Carvedilol route, ranked by trade value
Myanmar imports a wide range of carvedilol formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CARDIVAS 3.125MG TABLETS (Carvedilol Tab — accounts for $383.0K USD across 5 shipments. There are 39 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARDIVAS 3.125MG TABLETS (Carvedilol Tab | 5 | $383.0K | 44.0% |
| 2 | CARDIVAS 6.25MG TABLETS (Carvedilol Tabl | 4 | $246.9K | 28.4% |
| 3 | HARMLESS MEDICINES,CARVIALOB,Carvedilol3.125 mg Tablet , (10X10S) | 4 | $54.1K | 6.2% |
| 4 | HARMLESS MEDICINES,CARVIALOB Carvedilol3.125 mg Tablet (10X10S) | 3 | $20.4K | 2.3% |
| 5 | Carvid 3.125mg (Carvedilol USP 3.125 mg Tablets) (Myn Reg No. R 2704A 5293) PACK SIZE : 3x10's BATCH: DL0186 | 1 | $10.2K | 1.2% |
| 6 | Carvid 3.125mg (Carvedilol USP 3.125 mg | 1 | $9.8K | 1.1% |
| 7 | CARVIPRESS - 3.125 (CARVEDILOL 3.125MG T | 2 | $8.7K | 1.0% |
| 8 | CARVID 3.125 MG TABLETS CARVEDILOL TABLET USP 3.125 MG MAYANMAR REG NO: R2704 A5293 PACK SIZE: 3 X 10'S BATCH: CK0051NOS | 1 | $7.7K | 0.9% |
| 9 | HARMLESS MEDICINES-CARVIALOB CARVEDILOL | 1 | $7.3K | 0.8% |
| 10 | CARVEDILOL TABLETS USP 3.125MG (FILDILOL3.125) (6111 X 10 X 10S) | 1 | $7.0K | 0.8% |
Showing top 10 of 39 Carvedilol formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 11 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's carvedilol exports to Myanmar are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED, DELTA BIOPHARMA PRIVATE LIMITED — together account for 88% of total trade value on this route. The average shipment value of $14.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cardivas 6.25mg tablets (carvedilol tabl and harmless medicines,carvialob,carvedilol3.125 mg tablet , (10x10s), suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYIT MAHAR TRADING CO., LTD. is the largest importer with 7 shipments worth $477.3K USD — representing 55% of all carvedilol imports from India on this route. A total of 26 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $870.1K
- Avg. Shipment
- $14.0K
- Suppliers
- 21
- Buyers
- 26
- Transit (Sea)
- ~22 days
- Annual Growth
- +30.2%
Related Analysis
Other Carvedilol Routes
Unlock the Full India to Myanmar Carvedilol Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 62 shipments on this route.
Frequently Asked Questions — India to Myanmar Carvedilol Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Carvedilol to Myanmar?
The leading Indian exporters of Carvedilol to Myanmar are SUN PHARMACEUTICAL INDUSTRIES LIMITED , GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED, DELTA BIOPHARMA PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 72% of total trade value on this route.
Q What is the total value of Carvedilol exports from India to Myanmar?
India exports Carvedilol to Myanmar worth approximately $870.1K USD across 62 recorded shipments. The average value per shipment is $14.0K USD.
Q Which ports does India use to ship Carvedilol to Myanmar?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 11 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Myanmar for Carvedilol?
The average transit time for Carvedilol shipments from India to Myanmar is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Myanmar Carvedilol trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.2% with demand growth tracking at 25.2%. The route is ranked #14 among India's top Carvedilol export destinations globally.
Q How many suppliers are active on the India to Myanmar Carvedilol route?
There are currently 21 active Indian suppliers exporting Carvedilol to Myanmar. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 72% of total shipment value.
Q Who are the main importers of Carvedilol from India in Myanmar?
The leading importers of Indian Carvedilol in Myanmar include MYIT MAHAR TRADING CO., LTD. , MYIT MAHAR TRADING CO., LTD , GOLDEN SPIRIT TRADING CO. LTD, PYREX TRADING CO LTD, Pyrex Trading Co Ltd,. MYIT MAHAR TRADING CO., LTD. is the largest buyer with 7 shipments worth $477.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Carvedilol.
- 2.Supplier/Buyer Matching: 21 Indian exporters and 26 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 62 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
62 Verified Shipments
21 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists